As of 11:30 AM on the 15th, Celltrion is trading at 334,500 KRW, down 5.11% from the previous day. This represents a 12.89% decline compared to January 12. Celltrion is known as a protein and biopharmaceutical manufacturing company.

Today, foreigners have a tentative net purchase of 5,000 shares of Celltrion, while institutions have a net sale of 25,000 shares. Over the past five days, individual investors have net purchased 1,185,091 shares, whereas foreigners and institutions have net sold 599,501 shares and 626,850 shares, respectively.


On January 14, Celltrion became a market issue with a sharp drop following the clinical results of the COVID-19 treatment 'Rekkirona'.





[Table] Foreigners and Institutions Net Trading Volume (Unit: shares)

※ Source: AI Investment Assistant AI Rassiro


※ This article was generated in real-time by an automated article generation algorithm jointly developed by Asia Economy and the financial AI specialist company Thinkpool.


This content was produced with the assistance of AI translation services.

© The Asia Business Daily(www.asiae.co.kr). All rights reserved.

Today’s Briefing